閾剁墝浼氬憳绗?span style="font-size:1.5em;color:#f21">2骞滁/div> 璁块棶閲廁 3386691 缃戝潃:antibody.cnreagent.com 鍦ㄧ嚎鐣欒█
浜у搧鎼滅储
鎶椾綋 >> 鍏朵粬鎶椾綋
APC2鎶椾綋
APC2鎶椾綋鍥剧墖
浜よ揣鏈烔 1鍛?/span>
绱㈠彇璧勬枡鍙婃姤浠饵/span>
浜よ揣鏈烔 1鍛?/td>
浜у搧鍒悕: Anti-APC2
Anti-APC regulator of WNT signaling pathway 2 Antibody
浜у搧浠嬬粛
闈舵爣锛欬p style="text-indent: 2em;">APC2


浜у搧鍒悕锛欬p style="text-indent: 2em;">APCL锛 MRT74锛 APC2锛 APC regulator of WNT signaling pathway 2锛 APC regulator of WNT signaling pathway 2锛 adenomatous polyposis coli protein 2锛 APC2, WNT signaling pathway regulator锛 adenomatosis polyposis coli 2锛 adenomatous polyposis coli like锛


鑳屾櫙淇℃伅锛欬div style="text-indent: 2em;">APC2, which is also called APCL, is a deduced 2,303-amino acid protein that contains an N-terminal coiled-coil domain, followed by an armadillo domain and five 20-amino acid repeats. The human APC2 gene is mapped to chromosome 19p13.3. It is found that the 20-amino acid repeat domain of APCL could bind beta-catenin (CTNNB1) and deplete the intracellular beta-catenin pool. A reporter gene assay revealed that APCL could regulate interaction of beta-catenin with T cell-specific transcription factors (TCF7), although less efficiently than APC.

瀹夸富锛歊bt
绫诲瀷锛歅ab
鍚岀鍨婜IgG
搴旂敤锛歐B
绾寲鏂瑰紡锛氫翰鍜岀函鍖朁br/>鍋惰仈鐗╋細Unconjugated
鎬х姸锛氭恫浣
瀛樺偍婧舵恫锛氬弬闃呰鏄庝功
娴撳害锛欱atch dependent (Please refer to the vial label for the specific concentration.)
绋€閲婃瘮渚婜 Optimal dilutions/concentrations should be determined by the end user
鍌ㄥ瓨锛氱粡甯镐娇鐢ㄥ垯4掳C淇濆瓨銆?20掳C淇濆瓨涓嶈秴杩囦袱骞淬€傞伩鍏嶅弽澶嶅喕铻嶃€侟br/>娉ㄦ剰浜嬮」锛氫粎渚涘疄楠屽浣跨敤銆備笉閫傜敤浜庝汉绫绘垨鍔ㄧ墿鐨勪换浣曚复搴婏紝娌荤枟鎴栬瘖鏂敤閫斻€備笉閫傚悎鍔ㄧ墿鎴栦汉绫婚鐢ㄣ€侟/p>

鐩稿叧浜у搧
Baidu
map